Pharmaceuticals (67) | Development Agreements (67)
Browse by Company
-
Amylyx Pharmaceuticals, Inc. (1)
-
Canbiola, Inc. (1)
-
CNS Pharmaceuticals, Inc. (1)
-
Context Therapeutics Inc. (3)
-
CymaBay Therapeutics, Inc. (1)
-
ELITE PHARMACEUTICALS INC (1)
-
Exactus, Inc. (1)
-
Horizon Pharma plc (1)
-
Hoth Therapeutics, Inc. (1)
-
IntelGenx Technologies Corp. (1)
-
Kaleido Biosciences, Inc. (1)
-
Liquidia Corp (1)
-
MARINUS PHARMACEUTICALS INC (1)
-
MJ Holdings, Inc. (1)
-
Novan, Inc. (2)
-
Paratek Pharmaceuticals, Inc. (2)
-
Pulmatrix, Inc. (2)
-
REATA PHARMACEUTICALS INC (1)
-
RespireRx Pharmaceuticals Inc. (1)
-
Royalty Pharma plc (10)
-
Scopus BioPharma Inc. (8)
-
scPharmaceuticals Inc. (1)
-
SIGA TECHNOLOGIES INC (15)
-
Theravance Biopharma, Inc. (2)
-
Verona Pharma plc (1)
-
Virpax Pharmaceuticals, Inc. (4)
-
Zomedica Pharmaceuticals Corp. (2)
Recent Contracts
-
Amendment of Solicitation/Modification of Contract 000023, dated February 15, 2022, to Agreement, dated June 1, 2011, by and between SIGA and the Biomedical Advanced Research and...
(SIGA TECHNOLOGIES INC, Filed With SEC on May 5, 2022)
-
American Development Partners development agreement
(Canbiola, Inc., Filed With SEC on April 15, 2022)
-
Amendment, dated March 29, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of...
(MARINUS PHARMACEUTICALS INC, Filed With SEC on March 31, 2022)
-
Amendment Agreement by and between Verona Pharma plc and Ligand UK Development Limited dated March 24, 2022
(Verona Pharma plc, Filed With SEC on March 30, 2022)
-
Amendment of Solicitation/Modification of Contract 00006, dated April 29, 2021, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
(SIGA TECHNOLOGIES INC, Filed With SEC on March 3, 2022)
-
Amendment of Solicitation/Modification of Contract 00008, dated December 9, 2021, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
(SIGA TECHNOLOGIES INC, Filed With SEC on March 3, 2022)
-
Amendment of Solicitation/Modification of Contract 00020, dated November 8, 2021, to Agreement, dated May 13, 2011, by and between SIGA and the Biomedical Advanced Research and...
(SIGA TECHNOLOGIES INC, Filed With SEC on March 3, 2022)
-
Amendment of Solicitation/Modification of Contract 00022, dated November 8, 2021, to Agreement, dated June 1, 2011, by and between SIGA and the Biomedical Advanced Research and...
(SIGA TECHNOLOGIES INC, Filed With SEC on March 3, 2022)
-
Development Funding and Royalties Agreement, dated May 4, 2019, by and between Novan, Inc. and Ligand Pharmaceuticals Incorporated
(Novan, Inc., Filed With SEC on February 18, 2022)
-
Research, Development and Supply Agreement, dated as of December 9, 2019, and Deed of Amendment, dated as of July 26, 2021, by and between the Registrant and ICE S.p.A. (formerly...
(Amylyx Pharmaceuticals, Inc., Filed With SEC on December 16, 2021)
